Used in immunological research to quantify the terminal complement complex (C5b-9) in biological samples such as serum, plasma, or tissue extracts. This kit enables researchers to assess complement system activation, which is critical in studying inflammatory diseases, autoimmune disorders, and tissue injury mechanisms. It is widely applied in studies related to ischemia-reperfusion injury, neurodegenerative diseases, and renal pathologies where uncontrolled complement activation contributes to cell damage. The assay supports high-throughput analysis and provides a reliable measure of membrane attack complex formation, helping evaluate therapeutic interventions targeting the complement pathway.